The biopsy needle market size has grown strongly in recent years. It will grow from $1.41 billion in 2025 to $1.52 billion in 2026 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to reliance on traditional core needle biopsy methods, limited availability of vacuum-assisted biopsy devices, growing prevalence of cancer cases, increasing hospital and surgical center infrastructure, rising awareness of early diagnostic procedures.
The biopsy needle market size is expected to see strong growth in the next few years. It will grow to $2.06 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to technological advancements in image-guided and vacuum-assisted devices, development of innovative disposable needle designs, expansion of diagnostic clinics and pathology laboratories, rising investment in research and academic institutes, integration of ai and digital tools for precision diagnostics. Major trends in the forecast period include increasing adoption of image-guided biopsy procedures, rising preference for disposable biopsy needles, growth in minimally invasive diagnostic techniques, expansion of cancer and tumor screening programs, enhanced focus on patient safety and sterility standards.
The increasing demand for minimally invasive procedures is expected to propel the growth of the biopsy needle market going forward. Minimally invasive procedures involve medical interventions performed through small incisions or openings, reducing patient trauma and shortening recovery times. The demand for these procedures is rising due to their advantages, including faster recovery, lower risk of complications, reduced pain, and minimal scarring, making them more appealing to patients seeking safer and quicker treatment options. Biopsy needles support minimally invasive procedures by enabling precise tissue sampling, reducing the need for extensive surgical intervention, and facilitating faster diagnoses. For instance, in November 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, the total number of cosmetic minimally invasive procedures reached 25,442,640 in 2023, marking a 7% increase from 23,672,269 in 2022. Therefore, the increasing demand for minimally invasive procedures is driving the growth of the biopsy needle market.
Companies operating in the biopsy needle market are focusing on developing technologically advanced products, such as semi-automatic core biopsy instruments, to improve precision and ease of tissue sampling in minimally invasive procedures. Semi-automatic core biopsy instruments are medical devices that use a spring-loaded mechanism to quickly and accurately collect tissue samples with minimal manual effort. For instance, in May 2023, Argon Medical Devices Inc., a US-based medical device manufacturer, launched the SuperCore Advantage semi-automatic biopsy instrument. This disposable core biopsy needle provides consistent, high-quality tissue samples for accurate diagnosis. It features an ergonomic design, a sharp cutting edge for clean specimen retrieval, and an adjustable throw length to accommodate different lesion depths. The device enhances biopsy precision while minimizing patient discomfort, offering improved diagnostic capabilities.
In October 2023, Halma plc, a UK-based global life-saving technology company, completed the acquisition of AprioMed for an undisclosed sum. Through this acquisition, Halma seeks to strengthen its cancer diagnostic capabilities by incorporating AprioMed’s biopsy needle products for minimally invasive procedures. AprioMed AB, a Sweden-based medical device company, develops and manufactures biopsy needles to aid in diagnosing conditions such as cancer, complementing Halma’s IZI Medical Products portfolio.
Major companies operating in the biopsy needle market are Cardinal Health Inc., Medtronic plc, Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Hologic Inc., Cook Medical, Halma plc, Merit Medical Systems Inc., ConMed Corporation, Devicor Medical Products Inc., Shandong Weigao Group Medical Polymer Company Limited, Remington Medical Inc., Advin Health Care, Nikotech Healthcare Pvt. Ltd., Argon Medical Devices Inc., Geotek Medical Products Co. Ltd., Biomedical Srl, Hakko Co. Ltd., INRAD Inc.
North America was the largest region in the biopsy needle market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopsy needle market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biopsy needle market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the biopsy needle market by increasing costs for imported medical-grade metals and precision components used in needle manufacturing. Segments such as vacuum-assisted and fine needle aspiration devices are particularly impacted, with Asia-Pacific regions including China and India facing higher import duties. This has led to increased production costs and potential delays in device availability. On the positive side, tariffs have encouraged local manufacturing, innovation in reusable and disposable needle designs, and investment in domestic production capabilities.
The biopsy needle market research report is one of a series of new reports that provides biopsy needle market statistics, including biopsy needle industry global market size, regional shares, competitors with a biopsy needle market share, detailed biopsy needle market segments, market trends and opportunities, and any further data you may need to thrive in the biopsy needle industry. This biopsy needle market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A biopsy needle is a specialized medical device used to extract tissue samples from the body for diagnostic examination, often under imaging guidance. It is commonly employed to detect cancer, infections, or other abnormalities in organs and tissues. The primary purpose of a biopsy needle is to obtain a minimally invasive, precise sample for histopathological analysis.
The key types of biopsy needles include disposable and non-disposable needles. A disposable biopsy needle is a single-use device designed to collect tissue samples for diagnostic purposes and is discarded after one procedure to prevent cross-contamination. These devices include needle-based biopsy guns, vacuum-assisted biopsy systems, fine needle aspiration biopsy devices, and core needle biopsy instruments, used in both image-guided and non-image-guided procedures. They are applied in diagnosing cancers or tumors of the breast, lung, prostate, colon, stomach, liver, rectum, cervix uteri, and other organs. Key end users include hospitals and surgical centers, diagnostic clinics and pathology laboratories, ambulatory care centers, and research and academic institutes.
The biopsy needle market consists of sales of core needle biopsy devices, Menghini needles, and Francine needles. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The biopsy needle market size is expected to see strong growth in the next few years. It will grow to $2.06 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to technological advancements in image-guided and vacuum-assisted devices, development of innovative disposable needle designs, expansion of diagnostic clinics and pathology laboratories, rising investment in research and academic institutes, integration of ai and digital tools for precision diagnostics. Major trends in the forecast period include increasing adoption of image-guided biopsy procedures, rising preference for disposable biopsy needles, growth in minimally invasive diagnostic techniques, expansion of cancer and tumor screening programs, enhanced focus on patient safety and sterility standards.
The increasing demand for minimally invasive procedures is expected to propel the growth of the biopsy needle market going forward. Minimally invasive procedures involve medical interventions performed through small incisions or openings, reducing patient trauma and shortening recovery times. The demand for these procedures is rising due to their advantages, including faster recovery, lower risk of complications, reduced pain, and minimal scarring, making them more appealing to patients seeking safer and quicker treatment options. Biopsy needles support minimally invasive procedures by enabling precise tissue sampling, reducing the need for extensive surgical intervention, and facilitating faster diagnoses. For instance, in November 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, the total number of cosmetic minimally invasive procedures reached 25,442,640 in 2023, marking a 7% increase from 23,672,269 in 2022. Therefore, the increasing demand for minimally invasive procedures is driving the growth of the biopsy needle market.
Companies operating in the biopsy needle market are focusing on developing technologically advanced products, such as semi-automatic core biopsy instruments, to improve precision and ease of tissue sampling in minimally invasive procedures. Semi-automatic core biopsy instruments are medical devices that use a spring-loaded mechanism to quickly and accurately collect tissue samples with minimal manual effort. For instance, in May 2023, Argon Medical Devices Inc., a US-based medical device manufacturer, launched the SuperCore Advantage semi-automatic biopsy instrument. This disposable core biopsy needle provides consistent, high-quality tissue samples for accurate diagnosis. It features an ergonomic design, a sharp cutting edge for clean specimen retrieval, and an adjustable throw length to accommodate different lesion depths. The device enhances biopsy precision while minimizing patient discomfort, offering improved diagnostic capabilities.
In October 2023, Halma plc, a UK-based global life-saving technology company, completed the acquisition of AprioMed for an undisclosed sum. Through this acquisition, Halma seeks to strengthen its cancer diagnostic capabilities by incorporating AprioMed’s biopsy needle products for minimally invasive procedures. AprioMed AB, a Sweden-based medical device company, develops and manufactures biopsy needles to aid in diagnosing conditions such as cancer, complementing Halma’s IZI Medical Products portfolio.
Major companies operating in the biopsy needle market are Cardinal Health Inc., Medtronic plc, Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Hologic Inc., Cook Medical, Halma plc, Merit Medical Systems Inc., ConMed Corporation, Devicor Medical Products Inc., Shandong Weigao Group Medical Polymer Company Limited, Remington Medical Inc., Advin Health Care, Nikotech Healthcare Pvt. Ltd., Argon Medical Devices Inc., Geotek Medical Products Co. Ltd., Biomedical Srl, Hakko Co. Ltd., INRAD Inc.
North America was the largest region in the biopsy needle market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopsy needle market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biopsy needle market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the biopsy needle market by increasing costs for imported medical-grade metals and precision components used in needle manufacturing. Segments such as vacuum-assisted and fine needle aspiration devices are particularly impacted, with Asia-Pacific regions including China and India facing higher import duties. This has led to increased production costs and potential delays in device availability. On the positive side, tariffs have encouraged local manufacturing, innovation in reusable and disposable needle designs, and investment in domestic production capabilities.
The biopsy needle market research report is one of a series of new reports that provides biopsy needle market statistics, including biopsy needle industry global market size, regional shares, competitors with a biopsy needle market share, detailed biopsy needle market segments, market trends and opportunities, and any further data you may need to thrive in the biopsy needle industry. This biopsy needle market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A biopsy needle is a specialized medical device used to extract tissue samples from the body for diagnostic examination, often under imaging guidance. It is commonly employed to detect cancer, infections, or other abnormalities in organs and tissues. The primary purpose of a biopsy needle is to obtain a minimally invasive, precise sample for histopathological analysis.
The key types of biopsy needles include disposable and non-disposable needles. A disposable biopsy needle is a single-use device designed to collect tissue samples for diagnostic purposes and is discarded after one procedure to prevent cross-contamination. These devices include needle-based biopsy guns, vacuum-assisted biopsy systems, fine needle aspiration biopsy devices, and core needle biopsy instruments, used in both image-guided and non-image-guided procedures. They are applied in diagnosing cancers or tumors of the breast, lung, prostate, colon, stomach, liver, rectum, cervix uteri, and other organs. Key end users include hospitals and surgical centers, diagnostic clinics and pathology laboratories, ambulatory care centers, and research and academic institutes.
The biopsy needle market consists of sales of core needle biopsy devices, Menghini needles, and Francine needles. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Biopsy Needle Market Characteristics
3. Biopsy Needle Market Supply Chain Analysis
4. Global Biopsy Needle Market Trends and Strategies
5. Biopsy Needle Market Analysis of End Use Industries
7. Global Biopsy Needle Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Biopsy Needle Total Addressable Market (TAM) Analysis for the Market
9. Biopsy Needle Market Segmentation
10. Biopsy Needle Market Regional and Country Analysis
11. Asia-Pacific Biopsy Needle Market
12. China Biopsy Needle Market
13. India Biopsy Needle Market
14. Japan Biopsy Needle Market
15. Australia Biopsy Needle Market
16. Indonesia Biopsy Needle Market
17. South Korea Biopsy Needle Market
18. Taiwan Biopsy Needle Market
19. South East Asia Biopsy Needle Market
20. Western Europe Biopsy Needle Market
21. UK Biopsy Needle Market
22. Germany Biopsy Needle Market
23. France Biopsy Needle Market
24. Italy Biopsy Needle Market
25. Spain Biopsy Needle Market
26. Eastern Europe Biopsy Needle Market
27. Russia Biopsy Needle Market
28. North America Biopsy Needle Market
29. USA Biopsy Needle Market
30. Canada Biopsy Needle Market
31. South America Biopsy Needle Market
32. Brazil Biopsy Needle Market
33. Middle East Biopsy Needle Market
34. Africa Biopsy Needle Market
36. Biopsy Needle Market Competitive Landscape and Company Profiles
37. Biopsy Needle Market Other Major and Innovative Companies
40. Biopsy Needle Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Biopsy Needle Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses biopsy needle market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for biopsy needle? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biopsy needle market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Usage: Disposable; Non-Disposable2) By Product: Needle Based Biopsy Guns; Vacuum-Assisted Biopsy Devices; Fine Needle Aspiration Biopsy Devices; Core Needle Biopsy Devices
3) By Procedure: Image-Guided Procedures; Non-Image-Guided Procedures
4) By Application: Cancer Or Tumor; Breast; Lung; Prostate; Colon; Stomach; Liver; Rectum; Cervix Uteri; Other Applications
5) By End-User: Hospitals And Surgical Centers; Diagnostic Clinics And Pathology Laboratories; Ambulatory Care Centers; Research And Academic Institutes
Subsegments:
1) By Disposable: Coaxial Biopsy Needles; Chiba Needles; Jamshidi Needles2) By Non-Disposable: Reusable Tru-Cut Biopsy Needles; Reusable Menghini Needles; Reusable Francine Needles
Companies Mentioned: Cardinal Health Inc.; Medtronic plc; Becton Dickinson and Company; Stryker Corporation; Boston Scientific Corporation; Olympus Corporation; Hologic Inc.; Cook Medical; Halma plc; Merit Medical Systems Inc.; ConMed Corporation; Devicor Medical Products Inc.; Shandong Weigao Group Medical Polymer Company Limited; Remington Medical Inc.; Advin Health Care; Nikotech Healthcare Pvt. Ltd.; Argon Medical Devices Inc.; Geotek Medical Products Co. Ltd.; Biomedical Srl; Hakko Co. Ltd.; INRAD Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Biopsy Needle market report include:- Cardinal Health Inc.
- Medtronic plc
- Becton Dickinson and Company
- Stryker Corporation
- Boston Scientific Corporation
- Olympus Corporation
- Hologic Inc.
- Cook Medical
- Halma plc
- Merit Medical Systems Inc.
- ConMed Corporation
- Devicor Medical Products Inc.
- Shandong Weigao Group Medical Polymer Company Limited
- Remington Medical Inc.
- Advin Health Care
- Nikotech Healthcare Pvt. Ltd.
- Argon Medical Devices Inc.
- Geotek Medical Products Co. Ltd.
- Biomedical Srl
- Hakko Co. Ltd.
- INRAD Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.52 Billion |
| Forecasted Market Value ( USD | $ 2.06 Billion |
| Compound Annual Growth Rate | 7.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
